SARTORIUS STEDIM BIOTECH financial statements, including revenue, expenses, profit, and loss

The total revenue of 56S1 for the last quarter is 655.40 M EUR, and it's 7.22% lower compared to the previous quarter. The net income of Q3 24 is 25.50 M EUR.